The National Agency for the Control of AIDS (NACA) has assured Nigerians, particularly those living with HIV, that there is no shortage of antiretroviral drugs in the country.
In response to concerns raised following a recent World Health Organisation (WHO) press conference, NACA reaffirmed that the Federal Government has taken proactive steps to ensure a steady supply of HIV medication in the country.
The agency highlighted key government interventions, including the approval of $1.07 billion by the Federal Executive Council (FEC) for healthcare sector reforms under the Human Capital Opportunities for Prosperity and Equity (HOPE) program.
Additionally, N4.8 billion has been allocated specifically for HIV treatment, and the Nigerian Senate recently approved an extra N300 billion for the health sector in the 2025 budget.
The Director-General of NACA, Dr. Temitope Ilori, said that these financial commitments aim to mitigate the effects of the United States government’s temporary pause on aid, ensuring that Nigeria’s HIV response remains uninterrupted.
While acknowledging the long-standing partnership with the US government, the Nigerian government views this as an opportunity to strengthen local resource mobilisation and enhance the sustainability of HIV programmes.
“There is no shortage of drugs and consumables, and no immediate stop of services for HIV treatment, testing, and prevention in Nigeria. Our treatment centers and pharmacies will continue to have sufficient antiretroviral drugs, ensuring uninterrupted access to care,” she assured Nigerians.
NACA reaffirmed its commitment to the fight against HIV/AIDS, promising continued access to quality prevention, treatment, and care services for all Nigerians.
